Safety, tolerability and pharmacokinetic of multiple ascending doses of the EP-1 receptor antagonist ONO-8539, a potential new and novel therapy to overactive bladder in healthy young and elderly subjects

Authors
Category Primary study
JournalEuropean Urology, Supplements
Year 2010
This article has no abstract
Epistemonikos ID: 9f646989631286680bf0f2eb121674209ba83c6d
First added on: Feb 28, 2025